Justification for Testing Beyond Proposed Expiry Period
Testing beyond the expiry period allows manufacturers and regulators to:
Click to read the full article.
Stability Testing Types
Challenges in Real-Time Testing of Biosimilars
Real-time stability testing validates the proposed shelf life of biosimilars under recommended storage conditions (e.g., 2–8°C). Since biosimilars are administered parenterally and often stored under cold-chain conditions, real-time data is essential to ensure product safety and efficacy throughout the product lifecycle.
Click to read the full article.
Excipient Stability in Repeated Freeze-Thaw Cycles
Available from Pharma SOP:
Click to read the full article.
Impact of Transportation Conditions on Real-Time Stability Data
Real-time stability testing aims to replicate the actual storage conditions of a pharmaceutical product throughout its shelf life. However, transport introduces unique challenges that differ from static storage — often involving elevated temperature spikes, vibration, pressure changes, and potential packaging breaches. Without adequate evaluation, these transit-induced stresses can lead to discrepancies between lab-generated stability data and real-world product behavior.
Click to read the full article.
Intermediate Stability Testing in Lifecycle Management
While ICH Q1A(R2) focuses primarily on long-term and accelerated conditions, it also acknowledges the need for intermediate testing in specific scenarios. In lifecycle management, intermediate testing helps ensure product consistency and regulatory compliance during:
Click to read the full article.
Aggregation Pathways and Biologic Stability Challenges
Aggregation refers to the formation of dimers, oligomers, or larger aggregates of protein molecules due to structural instability. It can occur through various pathways and under different stress conditions, including thermal stress, mechanical agitation, freeze-thaw cycles, and changes in pH or ionic strength. Aggregates can be reversible or irreversible and are categorized based on their size:
Click to read the full article.
Validating Expiry Dating Derived from Accelerated Stability Data
Accelerated stability testing involves storing products under elevated temperature and humidity (e.g., 40°C ± 2°C / 75% RH ± 5%) to hasten degradation. It allows early estimation of shelf life, particularly in:
Click to read the full article.
Predictive Modeling of Thermal Excursion Risk
Predictive modeling of thermal excursion risk is transforming pharmaceutical stability management from a reactive to a proactive discipline. With accurate modeling, companies can prevent degradation, minimize product loss, and make informed QA decisions. As regulatory agencies increasingly recognize modeling-based justifications, pharmaceutical teams should adopt and validate these tools to strengthen compliance, ensure product quality, and safeguard global patient access.
Click to read the full article.
Sample Pooling Practices in Long-Term Stability Studies
Sample pooling refers to the practice of combining two or more product units—typically from the same batch, or across batches in justified scenarios—into a single test sample for stability evaluation. It is used to reduce the analytical burden and minimize material consumption, especially for tests such as assay, impurities, or dissolution.
Click to read the full article.
Comparative Case Review: Accelerated vs Real-Time Stability Outcomes
Regulatory bodies increasingly demand real-time data for final shelf-life claims. Accelerated data can supplement, but not replace, long-term evidence. If discrepancies occur:
Click to read the full article.